Future German Microbiology Testing Market Outlook
US$ 4,720.00
Highlights Comprehensive 983-page analysis of the German microbiology testing market. Major issues pertaining to the German microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current ...
February 2012
983 pages
Future Italian Microbiology Testing Market Outlook
US$ 4,720.00
Highlights Comprehensive 970-page analysis of the Italian microbiology testing market. Major issues pertaining to the Italian microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
February 2012
970 pages
Future Japanese Microbiology Testing Market Outlook
US$ 6,240.00
Highlights Comprehensive 976-page analysis of the Japanese microbiology testing market. Major issues pertaining to the Japanese microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
February 2012
976 pages
Future Spanish Microbiology Testing Market Outlook
US$ 4,720.00
Highlights Comprehensive 960-page analysis of the Spanish microbiology testing market. Major issues pertaining to the Spanish microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
February 2012
960 pages
Future UK Microbiology Testing Market Outlook
US$ 4,720.00
Highlights Comprehensive 978-page analysis of the UK microbiology testing market. Major issues pertaining to the UK microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current ...
February 2012
978 pages
Future US Microbiology Testing Market Outlook
US$ 7,520.00
Highlights Comprehensive 1,037-page analysis of the US microbiology testing market. Major issues pertaining to the US microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current ...
February 2012
1037 pages
Growth Opportunities in Transfusion Diagnostic Testing
US$ 22,880.00
During the next ten years, the transfusion diagnostics market will undergo significant transformation, which will result from the convergence of ... than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, ...
February 2012
800 pages
Future French Transfusion Diagnostic Testing Market Outlook
US$ 4,320.00
... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in French transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi-automated ...
February 2012
430 pages
Future German Transfusion Diagnostic Testing Market Outlook
US$ 4,320.00
... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in German transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi-automated ...
February 2012
426 pages
Future Italian Transfusion Diagnostic Testing Market Outlook
US$ 4,320.00
... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Italian transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi-automated ...
February 2012
412 pages
Future Japanese Transfusion Diagnostic Testing Market Outlook
US$ 5,440.00
... next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Japanese transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi- ...
February 2012
426 pages
Future Spanish Transfusion Diagnostic Testing Market Outlook
US$ 4,320.00
... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Spanish transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi-automated ...
February 2012
425 pages
Future UK Transfusion Diagnostic Testing Market Outlook
US$ 4,320.00
... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in UK transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi-automated ...
February 2012
422 pages
Future US Transfusion Diagnostic Testing Market Outlook
US$ 7,120.00
Highlights Comprehensive 460-pages market segmentation analysis of the US transfusion testing market. Major issues pertaining to the US transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
February 2012
460 pages
Unilever in the Global Food and Beverage Sector
US$ 1,520.00
A strategic assessment of Unilever, one of the world’s leading food and beverage companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s ...
January 2012
59 pages
Innovative Technologies And Their Impact on the US Diagnostics Market
US$ 3,880.00
The next ten years will be marked by significant technological developments in health care and biotechnology, which will drastically change the assumptions ... The report explores the impact of the most significant technological developments of the next ten years and their impact on the U.S. in vitro diagnostics ...
January 2012
85 pages
Future Cancer Diagnostic Technologies and Market Applications
US$ 1,480.00
... , immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. Contains 110 pages
December 2011
110 pages
Emerging Coagulation Tests and Suppliers Developing New Technologies
US$ 1,480.00
The report presents an overview of the clinical significance and market needs for major coagulation laboratory tests, as well as extensive listings of companies developing or marketing new coagulation technologies and products. Contains 125 pages and 20 tables
December 2011
125 pages
Emerging Cancer Molecular Diagnostic Tests
US$ 1,160.00
The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing molecular diagnostic technologies and products for cancer testing. Contains 45 pages and 1 table
December 2011
45 pages
Aloka in the Global Diagnostic Imaging Sector
US$ 1,520.00
A strategic assessment of Aloka, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...
November 2011
32 pages
Global Agrochemical Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
US$ 10,000.00
... well as over 100 syndicated multi-client studies and numerous proprietary single-client assignments. This database contains information on major agrochemical companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the Top 10 companies’ product and financial literature ...
November 2011
400 pages
Global Diagnostic Imaging Companies Financial Performance
US$ 1,960.00
Each company’s analysis provides: Sales estimates by division, geographic region, and modality. Five-year sales and operating profit performance. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 92 pages and 78 tables
November 2011
92 pages
Global Diagnostic Imaging Companies M&A, Business Organizations, and Senior Management
US$ 1,480.00
... , divestitures, and significant organizational changes. Current organizational structure. Management philosophy and attitudes toward the diagnostic imaging market. Background of key executives. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, ...
November 2011
92 pages
Global Diagnostic Imaging Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
US$ 10,000.00
... , factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading diagnostic imaging companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-a-vis the leading competitors. ...
November 2011
850 pages
Global Diagnostic Imaging Companies Major Facilities and Employees
US$ 1,480.00
... , manufacturing, and R&D facilities in the U.S. and abroad. New plants under construction. U.S. and international work force size and distribution. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 32 pages
November 2011
32 pages
Global Diagnostic Imaging Companies R&D Pipeline and Expenditures
US$ 1,480.00
... , research facilities, and staff. New technologies, systems, and applications in development, including their specifications and anticipated introduction dates. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 40 pages
November 2011
40 pages
Global Flavor and Fragrance Companies Major Facilities and Employees
US$ 1,480.00
For each company, the report provides: Production, compounding, creative, and R&D facilities by country. Workforce size. The companies analyzed in the report: Firmenich, Givaudan, T. Hasegawa, IFF, Mane, Quest, Robertet, Sensient, Symrise, and Takasago. Contains 52 pages
November 2011
52 pages
Global Paint and Coatings Companies Financial Performance
US$ 1,480.00
... Sales by division, geographic region and product line. Five-year sales and operating profit performance. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 75 ...
November 2011
75 pages
Global Paint and Coatings Companies Joints Ventures and Collaborations
US$ 1,480.00
... licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. ...
November 2011
40 pages
Global Paint and Coatings Companies M&A, Business Organizations, and Senior Management
US$ 1,480.00
... , the report provides: History of the company paints and coatings business evolution, which is important to understanding the corporate culture, management mentality, ... in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 80 pages ...
November 2011
80 pages
Global Paint and Coatings Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
US$ 10,160.00
... , factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading paints and coatings companies. To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis leading competitors. To ...
November 2011
500 pages
Global Paint and Coatings Companies Product Portfolios
US$ 1,480.00
The report presents extensive review of the major paints and coatings companies product lines. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 50 pages
November 2011
50 pages
Global Paint and Coatings Companies R&D Pipeline and Expenditures
US$ 1,480.00
For each company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies and products in development. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 35 pages
November 2011
35 pages
The US AIDS Diagnostics Market: Test Volumes, Sales Forecasts, and Supplier Shares
US$ 1,480.00
Summary This report presents a detailed analysis of the US AIDS diagnostics market, including test volume and sales forecasts for HIV-1/2, HIV ... , Western Blot and other confirmatory tests performed in the following market segments: Hospitals Commercial/Private Laboratories Blood Banks Physician Offices ...
October 2011
251 pages
French AIDS Diagnostic Market: Test Volumes, Sales Forecasts, and Supplier Shares
US$ 1,000.00
Summary This report presents a detailed analysis of the French AIDS diagnostics market, including test volume and sales forecasts for HIV-1/2, ... /Private Laboratories Blood Banks Physician Offices Public Health Laboratories In addition to test volume and sales projections, the report presents sales and ...
October 2011
251 pages
The 2011 Global Animal Health Market Dynamics and Trends
US$ 1,400.00
The report provides a strategic overview of the worldwide animal health market, including: Five-year forecasts for: Major market segments. Key ... of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such ...
September 2011
12 pages
The 2011 Leading Animal Health Companies Strategic Directions
US$ 1,560.00
The companies analyzed in this report include Bayer, Boehringer Ingelhein, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, Vetoquinol and Virbac. For each company, the report provides: Specific business, new product development and marketing strategies. Anticipated acquisitions, joint ventures and ...
September 2011
30 pages
The 2011 Leading Animal Health Companies Collaborative Arrangements
US$ 1,200.00
Each company analysis provides: Major joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Alpharma, Bayer, Elanco/Eli Lilly, Fort Dodge/Wyeth, Merial, Novartis, ...
September 2011
65 pages
The 2011 Leading Animal Health Companies Technological Know-How
US$ 1,520.00
Each company analysis provides: Internally developed and acquired animal health technologies, processes and related capabilities. Proprietary technologies and patent litigations. The companies analyzed in the report: Alpharma, Bayer, Elanco/Eli Lilly, Fort Dodge/Wyeth, Merial, Novartis, Pfizer, Schering- ...
September 2011
30 pages
